Barclays Maintains an 'Equalweight' on Covanta (CVA); Show Me the Money
Tweet Send to a Friend
Barclays maintains an 'Equalweight' on Covanta (NYSE: CVA), PT lowered by $1 to $18.
Barclays analyst says, "CVA reported Q4'10/FY'10 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "CVA reported Q4'10/FY'10 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
